111 related articles for article (PubMed ID: 2755529)
1. [The effects of gastric acid inhibitors].
van de Ven LL
Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1285. PubMed ID: 2755529
[No Abstract] [Full Text] [Related]
2. Peptic ulcer disease.
Hawker P
Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment of peptic ulcer syndrome.
Fielding JF
Ir Med J; 1982 Oct; 75(10):379-82. PubMed ID: 7174254
[No Abstract] [Full Text] [Related]
4. Pharmacologic control of gastric acid secretion in peptic ulcer.
Konturek SJ
Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
[No Abstract] [Full Text] [Related]
5. Acid suppression and ulcer healing: dichotomy, degree, and dilemma.
Hunt RH
Am J Gastroenterol; 1988 Sep; 83(9):964-6. PubMed ID: 2901221
[No Abstract] [Full Text] [Related]
6. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Bulgakov SA
Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
[No Abstract] [Full Text] [Related]
7. Pump blockers and ulcer disease.
Sachs G
N Engl J Med; 1984 Mar; 310(12):785-6. PubMed ID: 6230536
[No Abstract] [Full Text] [Related]
8. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
Grigor'ev PIa; Isakov VA
Sov Med; 1991; (3):39-43. PubMed ID: 1909055
[No Abstract] [Full Text] [Related]
9. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
10. Pirenzepine: a selective anticholinergic for peptic ulcer.
Drug Ther Bull; 1985 Apr; 23(8):29-31. PubMed ID: 3888582
[No Abstract] [Full Text] [Related]
11. [Use of gastrocepin in middle-aged and elderly patients with peptic ulcer].
Kapitanenko AM; Shastin IV; Karnaukhov IuN; Merkur'ev ND; Smirnov PA
Klin Med (Mosk); 1986 Mar; 64(3):95-6. PubMed ID: 3520141
[No Abstract] [Full Text] [Related]
12. Controlling acid secretion: individual variation in response.
Walt RP
Br J Clin Pract Suppl; 1994; 75():9-12; discussion 13. PubMed ID: 8060804
[No Abstract] [Full Text] [Related]
13. Treatment of ulcer disease.
Spenney JG
Ala J Med Sci; 1985 Jan; 22(1):49-53. PubMed ID: 3883827
[No Abstract] [Full Text] [Related]
14. [Recent state of therapy of peptic disease].
Pavlotzky M; Eshchar J
Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295
[No Abstract] [Full Text] [Related]
15. [Effect of dalargin on the level of gastric secretion].
Tepliuk SG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):67-8. PubMed ID: 3801139
[No Abstract] [Full Text] [Related]
16. Peptic ulcer diseases in children.
Acra SA; Nakagawa N; Ghishan FK
Compr Ther; 1991 Oct; 17(10):22-6. PubMed ID: 1764891
[No Abstract] [Full Text] [Related]
17. Acid rules--or does it?
Misiewicz JJ
J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):323-5. PubMed ID: 2876023
[No Abstract] [Full Text] [Related]
18. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
[TBL] [Abstract][Full Text] [Related]
19. Treating peptic ulcer: an ongoing challenge.
Cohen MH
J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
[No Abstract] [Full Text] [Related]
20. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
